Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 25 of 65 entries
View as:

Proton Beam or Intensity-Modulated Radiation Therapy in Preserving Brain Function in Patients With IDH Mutant Grade II or III Glioma

Phase: N/A Priority: Normal
NCT ID: NCT03180502 Org: User:
Start: 01/23/18 End: 05/31/25 Due: 05/31/26

Testing Whether Treating Breast Cancer Metastases With Surgery or High-Dose Radiation Improves Survival

Phase: N/A Priority: Normal
NCT ID: NCT02364557 Org: User:
Start: 12/24/14 End: 12/20/26 Due: 12/20/27

Comparing Proton Therapy to Photon Radiation Therapy for Esophageal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03801876 Org: User:
Start: 03/15/19 End: 12/21/31 Due: 12/21/32

Letrozole With or Without Paclitaxel and Carboplatin in Treating Patients With Stage II-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04095364 Org: User:
Start: 09/20/19 End: 02/01/28 Due: 02/01/29

Tailoring Therapy in Post-surgical Patients With Low-risk Endometrial Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06388018 Org: User:
Start: 01/27/25 End: 01/16/27 Due: 01/16/28

Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06580314 Org: User:
Start: 03/12/25 End: 12/31/34 Due: 12/31/35

A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04251052 Org: User:
Start: 09/01/20 End: 04/30/47 Due: 04/30/48

Testing the Addition of Targeted Radiation Therapy to Surgery and the Usual Chemotherapy Treatment (Pemetrexed and Cisplatin [or Carboplatin]) for Stage I-IIIA Malignant Pleural Mesothelioma

Phase: N/A Priority: Normal
NCT ID: NCT04158141 Org: User:
Start: 01/29/20 End: 11/20/23 Due: 11/20/24

Testing the Addition of Activity Monitoring With a Wearable Electronic Device to Improve Patient Care During Treatment for Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04878952 Org: User:
Start: 08/26/21 End: 08/12/24 Due: 08/12/25

Whole-Brain Radiation Therapy With or Without Hippocampal Avoidance in Limited Stage or Extensive Stage Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02635009 Org: User:
Start: 12/22/15 End: 04/30/27 Due: 04/30/28

Doxorubicin Hydrochloride and Cyclophosphamide Followed by Paclitaxel With or Without Carboplatin in Treating Patients With Triple-Negative Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02488967 Org: User:
Start: 07/26/15 End: 10/31/26 Due: 10/31/27

Assessing the Accuracy of Tumor Biopsies After Chemotherapy to Determine if Patients Can Avoid Breast Surgery

Phase: N/A Priority: Normal
NCT ID: NCT03188393 Org: User:
Start: 04/13/17 End: 12/01/22 Due: 12/01/23

Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06532279 Org: User:
Start: 06/02/25 End: 01/01/27 Due: 01/01/28

Copanlisib in Treating Patients With Persistent or Recurrent Endometrial Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02728258 Org: User:
Start: 09/16/16 End: 02/14/20 Due: 02/14/21

Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial

Phase: N/A Priority: Normal
NCT ID: NCT05327686 Org: User:
Start: 02/01/23 End: 06/15/28 Due: 06/15/29

Testing the Addition of the Drug Relugolix to the Usual Radiation Therapy for Advanced-Stage Prostate Cancer, The NRG Promethean Study

Phase: N/A Priority: Normal
NCT ID: NCT05053152 Org: User:
Start: 04/20/22 End: 02/01/29 Due: 02/01/30

Testing the Addition of the Drug Apalutamide to the Usual Hormone Therapy and Radiation Therapy After Surgery for Prostate Cancer, INNOVATE Trial

Phase: N/A Priority: Normal
NCT ID: NCT04134260 Org: User:
Start: 04/16/20 End: 11/01/26 Due: 11/01/27

Testing if High Dose Radiation Only to the Sites of Brain Cancer Compared to Whole Brain Radiation That Avoids the Hippocampus is Better at Preventing Loss of Memory and Thinking Ability

Phase: N/A Priority: Normal
NCT ID: NCT04804644 Org: User:
Start: 06/08/21 End: 07/01/30 Due: 07/01/31

Testing the Addition of an Anti-cancer Viral Gene Therapy, Toca 511/Toca FC, to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed Glioblastoma

Phase: N/A Priority: Normal
NCT ID: NCT04105374 Org: User:
Start: 01/31/20 End: 11/30/30 Due: 11/30/31

Comparing Whole Brain Radiotherapy Using a Technique That Avoids the Hippocampus to Stereotactic Radiosurgery in Patients With Cancer That Has Spread to the Brain and Come Back in Other Areas of the Brain After Earlier Stereotactic Radiosurgery

Phase: N/A Priority: Normal
NCT ID: NCT04588246 Org: User:
Start: 08/05/21 End: 08/06/24 Due: 08/06/25

E-Mindfulness Approaches for Living After Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06748222 Org: User:
Start: 06/12/25 End: 02/28/30 Due: 02/28/31

Radiation Therapy With or Without Apalutamide in Treating Patients With Recurrent Prostate Cancer, the BALANCE Trial

Phase: N/A Priority: Normal
NCT ID: NCT03371719 Org: User:
Start: 06/20/18 End: 03/01/26 Due: 03/01/27

Radiation Therapy vs. Observation Following Gemcitabine and Cisplatin for Inoperable Localized Liver Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02200042 Org: User:
Start: 09/29/14 End: 07/02/18 Due: 07/02/19

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05946213 Org: User:
Start: 12/14/23 End: 03/31/36 Due: 03/31/37

Comparing the Addition of Radiation Either Before or After Surgery for Patients With Brain Metastases

Phase: N/A Priority: Normal
NCT ID: NCT05438212 Org: User:
Start: 10/24/22 End: 03/16/27 Due: 03/16/28